Pay in 4 interest-free payments of $21.25 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
interference of MITF with ML-329 will be useful in characterizing the specific roles of MITF in melanoma and validate blockade of MITF function as a potential treatment of melanoma
desirable for a high number of disease targets
resulting in constitutive activation
31H-6-oxa-1
Naratriptan icorandil interference of MITF with ML-329Naratriptan is a selective 5 HT1 receptor subtype agonist for the treatment of migraine headache. Naratriptan binds with high affinity to human cloned 5 HT1B 1D receptors. Migraines are likely due to local cranial vasodilatation and or to the release of sensory neuropeptides (including substance P and calcitonin gene related peptide) through nerve endings in the trigeminal system. The therapeutic activity of AMERGE for the treatment of migraine
US$ 154.50
US$ 152.00
US$ 142.50
US$ 171.50
US$ 152.00
US$ 152.00
US$ 159.50
US$ 155.50
US$ 155.50
US$ 156.00
US$ 157.50
US$ 168.50
US$ 149.00
US$ 138.00
US$ 158.50
US$ 156.50
US$ 157.50
US$ 156.00
US$ 162.00